Gain Therapeutics, Inc.

GANX

Healthcare|Biotechnology|US

$1.03

+0.07 (+7.25%)

DCF Value

$0.61

Tangible Book / Share

$0.26

Cash / Share

$0.31

Next Earnings Report

Nov 11, 2026

EPS est. -$0.13 · Revenue est. $33.3K

Financing Filings (last 12 months)

Shelf registrations / offering prospectuses — latest Nov 28, 2025 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Mar 2031

Est. completion

Hypertension

GlycOxiTOD: Multimodal Vascular and Target-Organ Damage Registry

NCT06325800n=1,000

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Oct 2026

Validation of a Life Stories Methodologies in Long-Term Care Centres

NCT06569628

Recent Press Releases

Gain Therapeutics Announces Late-Breakers and Poster Presentations at Upcoming Scientific Conferences

Nov 5, 2026 · GlobeNewsWire

Sibylla Biotech Appoints Usman Azam CEO, Gianluca Fuggetta CFO, and Expands Executive Team to Drive Transition to Clinic

Oct 13, 2026 · GlobeNewsWire

Gain Therapeutics to Attend the 2026 Maxim Growth Summit

Oct 8, 2026 · GlobeNewsWire

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Oct 1, 2026 · GlobeNewsWire

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson's Disease and Movement Disorders

Sep 29, 2026 · GlobeNewsWire

Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference

Sep 17, 2026 · GlobeNewsWire

Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference

Aug 25, 2026 · GlobeNewsWire

SEC Filings (51)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

Filed	Form	What it is	Links
Oct 28, 2026	8-K	Material event	Document Index
Oct 1, 2026	8-K	Material event	Document Index
Sep 28, 2026	8-K	Material event	Document Index
Aug 11, 2026	10-Q	Quarterly report	Document Index
Aug 11, 2026	8-K	Material event	Document Index
Jul 16, 2026	8-K	Material event	Document Index
Jun 29, 2026	8-K	Material event	Document Index
Jun 25, 2026	8-K	Material event	Document Index
May 26, 2026	8-K	Material event	Document Index
May 11, 2026	10-Q	Quarterly report	Document Index
May 11, 2026	8-K	Material event	Document Index
Apr 28, 2026	ARS	Annual report to holders	Document Index
Apr 28, 2026	DEFA14A	Proxy / shareholder vote	Document Index
Apr 28, 2026	DEF 14A	Proxy / shareholder vote	Document Index
Mar 26, 2026	10-K	Annual report	Document Index
Mar 26, 2026	8-K	Material event	Document Index
Mar 18, 2026	8-K	Material event	Document Index
Feb 3, 2026	8-K	Material event	Document Index
Dec 18, 2025	8-K	Material event	Document Index
Dec 3, 2025	S-8	Employee stock plan	Document Index
Nov 28, 2025	8-K	Material event	Document Index
Nov 28, 2025	424B5	Offering prospectus	Document Index
Nov 12, 2025	10-Q	Quarterly report	Document Index
Nov 12, 2025	8-K	Material event	Document Index
Nov 7, 2025	S-3/A	Shelf registration	Document Index
Oct 14, 2025	8-K	Material event	Document Index
Oct 9, 2025	8-K	Material event	Document Index
Oct 6, 2025	8-K	Material event	Document Index
Aug 12, 2025	10-Q	Quarterly report	Document Index
Aug 12, 2025	8-K	Material event	Document Index
Jul 17, 2025	424B5	Offering prospectus	Document Index
Jul 17, 2025	8-K	Material event	Document Index
Jul 15, 2025	424B5	Offering prospectus	Document Index
Jun 30, 2025	8-K	Material event	Document Index
Jun 24, 2025	8-K	Material event	Document Index
May 28, 2025	S-3	Shelf registration	Document Index
May 14, 2025	10-Q	Quarterly report	Document Index
May 14, 2025	8-K	Material event	Document Index
Apr 29, 2025	ARS	Annual report to holders	Document Index
Apr 29, 2025	DEFA14A	Proxy / shareholder vote	Document Index